Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group.

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19.

PMID:
27995656
2.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

3.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group.

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
4.

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group.

Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889. Epub 2012 Jan 23.

PMID:
22271569
5.

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group.

Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.

PMID:
21708105
6.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group.

Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7.

PMID:
19837455
7.

[Abnormal ocular findings in the nursery and in the first few weeks of life: a mandatory, yet difficult and neglected screening].

Marcou V, Vacherot B, El-Ayoubi M, Lescure S, Moriette G.

Arch Pediatr. 2009 Sep;16 Suppl 1:S38-41. doi: 10.1016/S0929-693X(09)75299-6. French.

PMID:
19836666
8.

[Value and results of radioguided deep spinal biopsy].

Langer-Cherbit A, Chemla N, Vacherot B, Dupont AM, Godefroy D, Chevrot A.

J Radiol. 1994 Nov;75(11):603-8. Review. French.

PMID:
7844778
9.

[Ocular toxoplasmosis in AIDS].

Chakroun M, Meyohas MC, Pelosse B, Zazoun L, Vacherot B, Derouin F, Leport C.

Ann Med Interne (Paris). 1990;141(5):472-4. French.

PMID:
2256592
10.

[Bilateral paralysis of the 3d cranial nerve. Miller-Fisher syndrome].

Girard D, Vacherot B, Dehen H, Mondon H.

Ophtalmologie. 1989 Apr-May;3(2):171-2. French. No abstract available.

PMID:
2641103
11.

[Injuries of the excreting lacrimal ducts].

Vacherot B.

Soins Chir. 1989 Feb;(96):13-8. French. No abstract available.

PMID:
2704912
12.

[Eyelid injuries].

Vacherot B.

Soins Chir. 1989 Feb;(96):10-2. French. No abstract available.

PMID:
2704911
13.

[Myeloproliferative syndrome followed by mesothelioma after exposure to asbestos].

Vacherot B, Rossert J, Conso F, Fouret P, Touboul J.

Presse Med. 1983 Dec 3;12(44):2824. French. No abstract available.

PMID:
6228860
14.

[Chlamydia trachomatis perihepatitis (author's transl)].

Poynard T, Mazeron MC, Vacherot B, Florent C, Nataf C, Scieux C, Colimon R, Abadia R, Pérol Y.

Gastroenterol Clin Biol. 1982 Apr;6(4):321-5. French. No abstract available.

PMID:
7084581
15.

[Primary gastric tuberculosis, Case report].

Vacherot B, Saigot T, Cady J.

Med Chir Dig. 1981;10(4):341-3. French. No abstract available.

PMID:
7300490
16.

[Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].

Charasz N, Vacherot B, Dougados M, Bousser MG, Belaiche J, Cattan D.

Gastroenterol Clin Biol. 1979 Apr;3(4):371-4. French. No abstract available.

PMID:
159200

Supplemental Content

Loading ...
Support Center